Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-20T17:42:51.227Z Has data issue: false hasContentIssue false
  • English
  • Français

Economic aspects of bipolar disorder in Europe

Published online by Cambridge University Press:  16 April 2020

A. Lowin ,
M. Knapp ,
D. Grant ,
G. Gandhi  and
E.T. Edgell
A. Lowin
Affiliation:
Fourth Hurdle Consulting
M. Knapp
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry
D. Grant
Affiliation:
Fourth Hurdle Consulting
G. Gandhi
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK
E.T. Edgell
Affiliation:
European Health Outcomes Research, Lilly Research Centre, UK

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Monday, 6 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 151s
Copyright
Copyright © Elsevier, Paris 2002

References

(1)Dardennes, R.Lafuma, A.Watkins, S.Prophylactic treatment of mood disorders : cost effectiveness analysis comparing lithium and carbamazepine. Encéphale 1999; 25(5): pp 391–400.Google ScholarPubMed
(2)Wyatt, R.J.Henter, I.An economic evaluation of manicdepressive illness–1991. Social Psychiatry & Psychiatric Epidemiology 1995; 30(5): pp 213–219.Google Scholar
Submit a response

Comments

No Comments have been published for this article.